Publication:
Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge

dc.contributor.authorAndrade, Raul J.
dc.contributor.authorOrtega-Alonso, Aida
dc.contributor.authorIsabel Lucena, Maria
dc.contributor.authoraffiliation[Andrade, Raul J.] Univ Malaga, Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Enfermedades Digest, E-29071 Malaga, Spain
dc.contributor.authoraffiliation[Ortega-Alonso, Aida] Univ Malaga, Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Enfermedades Digest, E-29071 Malaga, Spain
dc.contributor.authoraffiliation[Andrade, Raul J.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
dc.contributor.authoraffiliation[Isabel Lucena, Maria] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
dc.contributor.authoraffiliation[Isabel Lucena, Maria] Univ Malaga, Hosp Univ Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, Serv Farmacol Clin, E-29071 Malaga, Spain
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderFondo Europeo de Desarrollo Regional– FEDER
dc.date.accessioned2023-02-12T02:22:27Z
dc.date.available2023-02-12T02:22:27Z
dc.date.issued2016-01-11
dc.description.versionSi
dc.identifier.citationAndrade RJ, Ortega-Alonso A, Lucena MI. "Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge". Expert Opin Drug Metab Toxicol. 2016 Jun;12(6):589-93
dc.identifier.doi10.1517/17425255.2016.1141896
dc.identifier.essn1744-7607
dc.identifier.issn1742-5255
dc.identifier.urihttp://hdl.handle.net/10668/19185
dc.identifier.wosID376661000001
dc.issue.number6
dc.journal.titleExpert opinion on drug metabolism & toxicology
dc.journal.titleabbreviationExpert opin. drug metab. toxicol.
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Virgen de la Victoria
dc.page.number589-593
dc.provenanceRealizada curación de contenido 11/09/2024
dc.publisherTaylor & Francis
dc.relation.projectIDPI04/1688
dc.relation.projectIDP10-CTS-6470
dc.relation.projectIDPI12-00620
dc.relation.projectIDPI 12-00378
dc.relation.projectIDAC-0073-2013
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.1517/17425255.2016.1141896
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPopulation
dc.subjectOutcomes
dc.subjectFailure
dc.subjectSpanish
dc.subject.decsAnimales
dc.subject.decsDiseño de fármacos
dc.subject.decsEnsayos clínicos como asunto
dc.subject.decsEvaluación preclínica de medicamentos
dc.subject.decsHumanos
dc.subject.decsPruebas de toxicidad
dc.subject.decsSalud global
dc.subject.meshAnimals
dc.subject.meshChemical and drug induced liver injury
dc.subject.meshClinical trials as topic
dc.subject.meshDrug design
dc.subject.meshDrug evaluation, preclinical
dc.subject.meshGlobal health
dc.subject.meshHumans
dc.subject.meshToxicity tests
dc.titleDrug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge
dc.typeeditorial
dc.volume.number12
dc.wostypeEditorial Material
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format